491 related articles for article (PubMed ID: 10816435)
1. Increased translation efficiency and antizyme-dependent stabilization of ornithine decarboxylase in amino acid-supplemented human colon adenocarcinoma cells, Caco-2.
Chabanon H; Persson L; Wallace HM; Ferrara M; Brachet P
Biochem J; 2000 Jun; 348 Pt 2(Pt 2):401-8. PubMed ID: 10816435
[TBL] [Abstract][Full Text] [Related]
2. Ornithine decarboxylase activity is inhibited by the polyamine precursor amino acids at the protein stability level in Caco-2 cells.
Chabanon H; Aubel C; Larvaron P; Villard C; Carraro V; Brachet P
Biochim Biophys Acta; 2005 May; 1723(1-3):74-81. PubMed ID: 15716048
[TBL] [Abstract][Full Text] [Related]
3. Antizyme-dependent and -independent mechanisms are responsible for increased spermidine transport in amino acid-restricted human cancer cells.
Aubel C; Chabanon H; Persson L; Thiman L; Ferrara M; Brachet P
Biochem Biophys Res Commun; 1999 Mar; 256(3):646-51. PubMed ID: 10080953
[TBL] [Abstract][Full Text] [Related]
4. Tumour promoter mediated altered expression and regulation of ornithine decarboxylase and S-adenosylmethionine decarboxylase in H-ras-transformed fibrosarcoma cell lines.
Voskas D; Mader R; Lee J; Hurta RA
Biochem Cell Biol; 2001; 79(1):69-81. PubMed ID: 11235918
[TBL] [Abstract][Full Text] [Related]
5. Anti-tumor activity of antizyme which targets the ornithine decarboxylase (ODC) required for cell growth and transformation.
Iwata S; Sato Y; Asada M; Takagi M; Tsujimoto A; Inaba T; Yamada T; Sakamoto S; Yata J; Shimogori T; Igarashi K; Mizutani S
Oncogene; 1999 Jan; 18(1):165-72. PubMed ID: 9926931
[TBL] [Abstract][Full Text] [Related]
6. Cellular control of ornithine decarboxylase activity by its antizyme.
Heller JS; Canellakis ES
J Cell Physiol; 1981 May; 107(2):209-17. PubMed ID: 7251680
[TBL] [Abstract][Full Text] [Related]
7. Regulation of ornithine decarboxylase activity and polyamine transport by agmatine in rat pulmonary artery endothelial cells.
Babál P; Ruchko M; Campbell CC; Gilmour SP; Mitchell JL; Olson JW; Gillespie MN
J Pharmacol Exp Ther; 2001 Feb; 296(2):372-7. PubMed ID: 11160620
[TBL] [Abstract][Full Text] [Related]
8. Antizyme inhibitor is rapidly induced in growth-stimulated mouse fibroblasts and releases ornithine decarboxylase from antizyme suppression.
Nilsson J; Grahn B; Heby O
Biochem J; 2000 Mar; 346 Pt 3(Pt 3):699-704. PubMed ID: 10698696
[TBL] [Abstract][Full Text] [Related]
9. Stable siRNA-mediated silencing of antizyme inhibitor: regulation of ornithine decarboxylase activity.
Choi KS; Suh YH; Kim WH; Lee TH; Jung MH
Biochem Biophys Res Commun; 2005 Mar; 328(1):206-12. PubMed ID: 15670771
[TBL] [Abstract][Full Text] [Related]
10. Ornithine decarboxylase activity is associated with proliferation but not with T3-induced differentiation of Caco-2 cells.
Jumarie C; Malo C
J Cell Physiol; 1995 Dec; 165(3):639-46. PubMed ID: 7593244
[TBL] [Abstract][Full Text] [Related]
11. Regulation of ornithine decarboxylase in a transformed cell line that overexpresses translation initiation factor eIF-4E.
Shantz LM; Hu RH; Pegg AE
Cancer Res; 1996 Jul; 56(14):3265-9. PubMed ID: 8764119
[TBL] [Abstract][Full Text] [Related]
12. Rapid expression of ornithine decarboxylase mRNA in a macrophage-like cell line: cAMP repression of the requirement for prior protein synthesis.
Shurtleff SA; McElwain CM; Taffet SM
J Cell Physiol; 1988 Mar; 134(3):453-9. PubMed ID: 2832424
[TBL] [Abstract][Full Text] [Related]
13. Antizyme inhibitor: a defective ornithine decarboxylase or a physiological regulator of polyamine biosynthesis and cellular proliferation.
Keren-Paz A; Bercovich Z; Kahana C
Biochem Soc Trans; 2007 Apr; 35(Pt 2):311-3. PubMed ID: 17371267
[TBL] [Abstract][Full Text] [Related]
14. The effect of transport system A and N amino acids and of nerve and epidermal growth factors on the induction of ornithine decarboxylase activity.
Rinehart CA; Viceps-Madore D; Fong WF; Ortiz JG; Canellakis ES
J Cell Physiol; 1985 Jun; 123(3):435-41. PubMed ID: 2859293
[TBL] [Abstract][Full Text] [Related]
15. Regulation of ornithine decarboxylase gene expression in MCF-7 breast cancer cells by antiestrogens.
Thomas T; Trend B; Butterfield JR; Jänne OA; Kiang DT
Cancer Res; 1989 Nov; 49(21):5852-7. PubMed ID: 2790797
[TBL] [Abstract][Full Text] [Related]
16. Nuclear translocation of antizyme and expression of ornithine decarboxylase and antizyme are developmentally regulated.
Gritli-Linde A; Nilsson J; Bohlooly-Y M; Heby O; Linde A
Dev Dyn; 2001 Mar; 220(3):259-75. PubMed ID: 11241834
[TBL] [Abstract][Full Text] [Related]
17. Crystal structure of human ornithine decarboxylase at 2.1 A resolution: structural insights to antizyme binding.
Almrud JJ; Oliveira MA; Kern AD; Grishin NV; Phillips MA; Hackert ML
J Mol Biol; 2000 Jan; 295(1):7-16. PubMed ID: 10623504
[TBL] [Abstract][Full Text] [Related]
18. Ultraviolet radiation induction of ornithine decarboxylase in rat keratinocytes.
Rosen CF; Gajic D; Drucker DJ
Cancer Res; 1990 May; 50(9):2631-5. PubMed ID: 2328489
[TBL] [Abstract][Full Text] [Related]
19. Ornithine decarboxylase induction during B1 progression of normal and Rous sarcoma virus-transformed cells.
Haddox MK; Magun BE; Russell DH
Cancer Res; 1980 Mar; 40(3):604-8. PubMed ID: 6258784
[TBL] [Abstract][Full Text] [Related]
20. Modulatory effect of dexamethasone on ornithine decarboxylase activity and gene expression: a possible post-transcriptional regulation by a neutral metalloprotease.
Nguyen-Ba G; Robert S; Dhalluin S; Tapiero H; Hornebeck W
Cell Biochem Funct; 1994 Jun; 12(2):121-8. PubMed ID: 8044888
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]